Regarding specific markers, CD56 expression has been associated with DMNT3A and AML-like mutations (NPM1, FLT3, IDH1, and RUNX1 genes) (Euro-MDS group 7), and CD15 expression with U2AF1 mutations (Euro-MDS group 4). This evidence concerns the gene NPM1 and myelodysplastic syndrome.